» Articles » PMID: 17620443

Pelvic Floor Disorders, Diabetes, and Obesity in Women: Findings from the Kaiser Permanente Continence Associated Risk Epidemiology Study

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2007 Jul 11
PMID 17620443
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We examined associations between obesity and diabetes and female pelvic floor disorders (PFDs), stress urinary incontinence (SUI), overactive bladder (OAB), and anal incontinence (AI) in community-dwelling women.

Research Design And Methods: Women were screened for PFD using a validated mailed survey. Diabetes status, glycemic control, and diabetes treatment were extracted from clinical databases, while other risk factors for PFDs were obtained through self-report. Women were categorized hierarchically as nonobese/nondiabetic (reference), nonobese/diabetic, obese/nondiabetic, and obese/diabetic.

Results: Of 3,962 women, 393 (10%) had diabetes. In unadjusted analyses, women with diabetes and women who were obese had greater odds of having PFDs. Among women with diabetes, being obese was associated with SUI and OAB. After adjusting for confounders, we found that obese/diabetic women were at the highest likelihood of having SUI (odds ratio 3.67 [95% CI 2.48-5.43]) and AI (2.09 [1.48-2.97]). The odds of having OAB among obese women was the same for obese/diabetic women (2.97 [2.08-4.36]) and obese/nondiabetic women (2.93 [2.33-3.68]). Nonobese/diabetic women had higher odds of SUI (1.90 [1.15-3.11]) but did not differ significantly in their OAB (1.45 [0.88-2.38]) and AI (1.33 [0.89-2.00]) prevalence from nonobese/nondiabetic women.

Conclusions: Given the impaired quality of life experienced by women with PFDs, health care providers should counsel women that obesity and diabetes may be independent modifiable risk factors for PFDs.

Citing Articles

Risk factors associated with the severity of overactive bladder among Syrian patients with type 2 diabetes.

Khadour F, Khadour Y, Alhatem W, Barroush D Sci Rep. 2024; 14(1):16547.

PMID: 39020001 PMC: 11255225. DOI: 10.1038/s41598-024-67326-w.


Incidence of Urinary Incontinence During the Postpartum Period in Rajavithi Hospital: A Prospective Cohort Study.

Naorungrot J, Sangnucktham T Int Urogynecol J. 2024; 35(8):1621-1626.

PMID: 38951165 DOI: 10.1007/s00192-024-05833-0.


Association between Sitting Time and Urinary Incontinence in the US population: Data from the National Health and Nutrition Examination Survey (NHANES) 2007 to 2018.

Di X, Yuan C, Xiang L, Wang G, Liao B Heliyon. 2024; 10(6):e27764.

PMID: 38510052 PMC: 10950664. DOI: 10.1016/j.heliyon.2024.e27764.


Pathophysiology of Overactive Bladder and Pharmacologic Treatments Including β3-Adrenoceptor Agonists -Basic Research Perspectives.

Kwon J, Kim D, Cho K, Hashimoto M, Matsuoka K, Kamijo T Int Neurourol J. 2024; 28(Suppl 1):12-33.

PMID: 38461853 PMC: 10932578. DOI: 10.5213/inj.2448002.001.


Effects of Sleeve Gastrectomy on Pelvic Floor Disorders in Female Patients with Severe Obesity: a Prospective Study.

Gunes Y, Fersahoglu M, Esen Bulut N, Cakmak A, Ergin A, Teke E Obes Surg. 2023; 33(10):3069-3076.

PMID: 37428362 DOI: 10.1007/s11695-023-06725-w.